Press release
What's driving the Thalassemia Market growth? Key Players are ApoPharma Inc., Novartis, Teva Pharmaceuticals, Fresenius Kabi, Pfizer, bluebird bio, Acceleron Pharma, Incyte, Celgene, GSK, Vifor Pharma, Lonza, La Jolla Pharmaceutical Company and others
Global Thalassemia Market Outlook, Trend, Share, Size, Application, Growth and Forecast
Thalassemia market research report lends a hand to business in every sphere of trade to take first-class decisions, to tackle the toughest business questions and reduce the risk of failure. The important highlights of Thalassemia market report are key market dynamics, current market scenario and future prospects of the sector. Thalassemia market research report is an absolute overview of the market that spans various aspects such as product definition, customary vendor landscape, and market segmentation based on various parameters such as type of product, its components, type of management and geography.
Global Thalassemia Market is expected to rise from its initial estimated value of USD 1.99 billion to a projected value of USD 4.36 billion by 2026, registering a CAGR of 10.29% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing concern and awareness regarding the disease globally.
Download FREE | Sample Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-thalassemia-market
Key Market Competitors: Global Thalassemia Market
ApoPharma Inc., Novartis, Teva Pharmaceuticals, Fresenius Kabi, Pfizer, bluebird bio, Acceleron Pharma, Incyte, Celgene, GSK, Vifor Pharma, Lonza, La Jolla Pharmaceutical Company, Ionis Pharmaceuticals, Inc., Kiadis Pharma, Gamida Cell Ltd., Sangamo Therapeutics, Inc.
Market Drivers
Increasing prevalence of the disease globally without any viable treatment options available for curing the disease; this factor is expected to drive the market growth
Growth in development of pipeline drugs and development of new therapies because of R&D activities and investments by the various authorities; this factor is expected to drive the market growth
Market Restraint
Lack of viable treatment options commercialized for the treatment of disease/disorder rather than the symptoms associated with the disease; this factor is expected to restrain the market growth
High cost of treatment for the disorder is expected to act as a restraint to the market growth
Customization of the Report:
This report can be customized to meet the client’s requirements. Please connect with our sales team (sopan.gedam@databridgemarketresearch.com), who will ensure that you get a report that suits your needs.
Table of Content
Chapter 1 Methodology & Scope
1.1 Methodology
Initial data exploration
Statistical model and forecast
Industry insights and validation
Definition and forecast parameters
1.2 Data Sources
Secondary
Primary
Chapter 2 Executive Summary
2.1 Thalassemia industry 360 degree synopsis, 2019 - 2026
Regional trends
Solution trends
Chapter 3 Thalassemia Industry Insights
Industry segmentation
Industry landscape, 2019 - 2026
Industry ecosystem analysis
Industry participant analysis
Major pain points
Industry impact forces
Growth drivers
Technological advancements
Emerging trend across E-Commerce industry
Industry pitfalls and challenges
Lack of logistics control
Growth potential analysis
Porter's analysis
Company market share analysis, 2016
3.9.1 Overview of key players
Development of competitive positioning over time
PESTEL analysis
Chapter 4 Thalassemia Market, By Solution
4.1 Thalassemia market share by Application, 2016 & 2024
Market estimates and forecast, by region, 2019 - 2026 (USD Billion) … And Continue… Ask For FREE TOC
Download FREE | TOC At https://databridgemarketresearch.com/toc/?dbmr=global-thalassemia-market
Segmentation: Global Thalassemia Market
By Thalassemia Type
Alpha Thalassemia
Beta Thalassemia
By Therapeutic Class
Iron Chelating Drugs
Exjade/Jadenu (deferasirox)
By Pipeline
Gene Therapy
LentiGlobin
By End-User
Hospitals
Clinics
Research Institutes
Laboratories
By Geography
North America
Europe
Asia-Pacific
Middle East & Africa
Key Developments in the Market:
In April 2019, CELGENE CORPORATION and Acceleron Pharma, Inc. announced that CELGENE had submitted a Biologics License Application (BLA) for “luspatercept” with the U.S. F.D.A. (United States Food & Drug Administration). This will help in faster commercialization and development of drugs for patients suffering from blood diseases.
In January 2019, Vifor Pharma announced positive results from their phase-I trial of “VIT-2763” an oral ferroportin inhibitor. The drug being developed for transportation of iron from one cell to another has shown signs in reduction of serum iron in a dose-dependent state.
Competitive Analysis: Global Thalassemia Market
Global thalassemia market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of thalassemia market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Reasons to Purchase this Report
Current and future of global thalassemia market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Speak to The Author at https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-thalassemia-market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's driving the Thalassemia Market growth? Key Players are ApoPharma Inc., Novartis, Teva Pharmaceuticals, Fresenius Kabi, Pfizer, bluebird bio, Acceleron Pharma, Incyte, Celgene, GSK, Vifor Pharma, Lonza, La Jolla Pharmaceutical Company and others here
News-ID: 1728119 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for Thalassemia
Beta Thalassemia Market Trends, Treatment Landscape, and Growth Opportunities
Introduction
Beta thalassemia is a genetic blood disorder caused by mutations in the beta-globin gene, leading to reduced or absent production of the beta-globin chains of hemoglobin. This results in anemia, fatigue, and a range of complications that can be life-threatening if untreated. The severity of beta thalassemia varies from thalassemia minor, which typically requires no treatment, to thalassemia major (Cooley's anemia), which can lead to severe symptoms and require frequent…
Global Thalassemia Market Size – Forecast to 2026
The findings reviewed by GME stated that the Global Thalassemia Market will expand with a CAGR value of 10.2 percent from 2021 to 2026. Several drivers are likely to accelerate the thalassemia market further, including an increasing occurrence of thalassemia, growing public awareness, expanding expenditure in research & development, and the growing need for improved curative gene therapy.
Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and…
Thalassemia Market to witness steady growth increase by 2024
Zion Market Research analysts forecast the latest report on "Thalassemia Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016-2024", according to their latest report the Thalassemia Market report covers the overall and all-inclusive analysis of the Thalassemia Market with all its factors that have an impact on market growth. The Thalassemia Market's complete outline is crystal clear penned down in the global Thalassemia Market research report such that…
Thalassemia Treatment Market is driven by increase in number of altered thalasse …
Thalassemia Treatment Market - Snapshot
The global thalassemia treatment market is driven by increase in number of altered thalassemia genes across the globe. The global market was valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2026 to reach US$ 1,639.6 Mn by 2026. The global market is witnessing high growth owing to increase in blood transfusion and chelation therapy…
Thalassemia - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Thalassemia - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape.
Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms…
Global Thalassemia Market Report: 2016 Edition
Thalassemia is a hereditary blood disorder in which a person’s body makes an abnormal form of hemoglobin, which is the protein molecule in red blood cells (RBCs), which carries oxygen. The disorder results in unwarranted damage of red blood cells, which leads to anemia. Anemia is a condition in which the body doesn’t have adequate amount of normal and healthy red blood cells. There are majorly two types of thalassemia…
